Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoin dolines and their use to reduce TNFalpha levels

Details for Australian Patent Application No. 2002320734 (hide)

Owner Celgene Corporation

Inventors Man, Honwah; Chen, Roger Shen-Chu; Stirling, David I; Muller, George W

Agent Pizzeys

Pub. Number AU-B-2002320734

Parent 14138

Filing date 20 December 2002

Wipo publication date 3 April 2003

Acceptance publication date 1 September 2005

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 031/445 - Non-condensed piperidines, e.g. piperocaine

Event Publications

16 January 2003 Complete Application Filed

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002320734

1 September 2005 Application Accepted

  Published as AU-B-2002320734

5 January 2006 Standard Patent Sealed

9 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002320735-Controlling fuel vapor venting in a fuel tank

2002320733-Improvements in Adaptor Parts for Ground Engaging Elements